Fibre Capsules
Natural health product licensed in Canada
- Licence holder
- Teva Canada Limited
- NPN or DIN-HM
- 80010896
- Status
- Active licence
- Licence date
- 11 June 2009
- Revision date
- 19 December 2022
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Gélatine, Dioxyde de titane, Shellac, Poly(sorbate) 80, FD & C bleu #1, Lauryl sulfate de sodium, Couleur caramel
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes et enfants | minimum: 12 years | 5 Capsule | maximum: 3 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
For gentle relief of constipation and/or irregularity. Lowers Cholesterol level. Promotes heart health. May reduce the risk or coronary heart disease by lowering blood cholesterol levels when used as part of a low fat, low-cholesterol diet. Souble fibre from psyllium, when included as part of a diet low in saturated fat and cholesterol, may redice risk of coronary heart disease by lowering cholesterol levels. Promotes digestive health or digestive wellness by relieveing irregularity.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80010896
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2022. Photograph the packaging to check whether it has changed. Photograph the packaging